Medtronic PLC (MDT)
Return on assets (ROA)
Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | Apr 30, 2022 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 3,676,000 | 3,676,000 | 3,758,000 | 3,758,000 | 5,039,000 |
Total assets | US$ in thousands | 89,981,000 | 89,981,000 | 90,948,000 | 90,948,000 | 90,981,000 |
ROA | 4.09% | 4.09% | 4.13% | 4.13% | 5.54% |
April 30, 2024 calculation
ROA = Net income ÷ Total assets
= $3,676,000K ÷ $89,981,000K
= 4.09%
To analyze Medtronic PLC's return on assets (ROA) over the past few years, we observe a trend of declining ROA figures. Specifically, Medtronic PLC's ROA decreased from 5.54% as of April 30, 2022, to 4.09% as of April 30, 2024. This decline in ROA indicates that the company's ability to generate profits from its assets has weakened over the period under review. It is important for stakeholders to assess the factors contributing to this decline in ROA and evaluate the company's operational efficiency and asset utilization to identify potential areas for improvement.
Peer comparison
Apr 30, 2024
Company name
Symbol
ROA
Medtronic PLC
MDT
4.09%
BioLife Solutions Inc
BLFS
-5.05%
CONMED Corporation
CNMD
5.74%
LivaNova PLC
LIVN
2.52%
Masimo Corporation
MASI
-11.61%
TransMedics Group Inc
TMDX
4.41%